Arno de Wilde
Private Equity Investor at EQT Life Sciences Group BV
Network origin in Arno de Wilde first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Utrecht
34
| College/University | Other Consumer Services | 34 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
26
| Subsidiary | Investment Managers | 26 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
Vrije Universiteit Amsterdam
20
| College/University | Other Consumer Services | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Arno de Wilde via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Het Concertgebouw NV
 Het Concertgebouw NV Movies/EntertainmentConsumer Services Het Concertgebouw NV provides bands, orchestra and music entertainment services. It offers purchase tickets, tours, categories and charts. The company was founded on July 8, 1882 and is headquartered in Amsterdam, the Netherlands. | Movies/Entertainment | Director/Board Member Director/Board Member | |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree | |
Waterland Private Equity Investments BV
 Waterland Private Equity Investments BV Investment ManagersFinance Waterland Private Equity Investments BV is a Private Equity firm, a subsidiary of Waterland Management Holding IV BV founded in 1999 by Robertus H.L.M. Thielen. Waterland Private Equity Investments BV is headquartered in Bussum with additional offices around the world. | Investment Managers | Private Equity Investor General Counsel | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Tilburg | College/University | Corporate Officer/Principal Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Twente | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Director/Board Member Graduate Degree Undergraduate Degree Doctorate Degree | |
Triodos Bank NV
 Triodos Bank NV Regional BanksFinance Triodos Bank NV provides commercial banking and lending services to cultural, social, and environmental organizations. It offers personal and business banking services including loans, overdrafts, current, saving, deposit, and reserve accounts. The firm focuses on the renewable energy, social housing, healthcare, fair trade, organic food, farming, and social development fields. The company was founded in 1968 and is headquartered in Utrecht, the Netherlands. | Regional Banks | Chairman Corporate Officer/Principal | |
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Leiden | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Groningen | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Corporate Officer/Principal Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| The International Society for Stem Cell Research | President Director/Board Member | ||
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Akzo Nobel Ltda.
 Akzo Nobel Ltda. Industrial SpecialtiesProcess Industries Akzo Nobel Ltda. provides decorative paints, performance coatings and specialty chemicals. Its products include catalysts, polymers, surfactants, and functional, pulp & paper chemicals. The firm's brands include Dulux, Sikkens and Eka. The company is headquartered in Sao Paulo, Brazil. | Industrial Specialties | Human Resources Officer General Counsel | |
| ABN AMRO BANK N.V. | Major Banks | Compliance Officer Director/Board Member | |
| LSP Services Deutschland GmbH | Investment Managers | Private Equity Investor Private Equity Analyst | |
International Society of Differentiation, Inc.
 International Society of Differentiation, Inc. Miscellaneous Commercial ServicesCommercial Services International Society of Differentiation, Inc. engages in development, research and communication in the fields of cell and developmental biology, molecular biology and oncology. The company was founded by Jean Louis Auguste Brachet in 1971 and is headquartered in St. Paul, MN. | Miscellaneous Commercial Services | President President | |
| Stichting Steun Alzheimercentrum VUmc | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member | |
Mckinsey & Co. /Amsterdam/
 Mckinsey & Co. /Amsterdam/ Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., Mckinsey & Co. /Amsterdam/ provides management consultancy services. The company is based in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal Consultant / Advisor | |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Chairman | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
The World Bank (Research)
 The World Bank (Research) Investment ManagersFinance The World Bank (Research) (World Bank-Research) is the investment research division of The World Bank, an international financial institution headquartered in Washington, DC. It provides loans and grants to the governments of low- and middle-income countries for the purpose of pursuing capital projects. World Bank-Research provides research to developing nations to aid economic advancement. | Investment Managers | Economist Consultant / Advisor | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Founder Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
365 Capital Management BV
 365 Capital Management BV Investment ManagersFinance 365 Capital Management BV is an Independent private equity firm founded by Boudewijn Molenaar, Steven Albers, Hayo van Houten and Reinaert Molenaar. The firm is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Investor | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| Netherlands | 26 |
| Belgium | 9 |
| United States | 7 |
| Switzerland | 5 |
| France | 3 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 13 |
| Finance | 12 |
| Commercial Services | 6 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 241 |
| Corporate Officer/Principal | 97 |
| Graduate Degree | 65 |
| Private Equity Investor | 64 |
| Undergraduate Degree | 42 |
Most connected contacts
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Martijn Kleijwegt | 33 |
| Marjan Johanna Oudeman | 32 |
| René Kuijten | 30 |
| Rudy Dekeyser | 29 |
| Jacqueline Rijsdijk | 24 |
| Caroline Princen | 24 |
| Lise Kingo | 23 |
| John Paul de Koning | 21 |
| Anne Portwich | 16 |
| Vincent Brichard | 15 |
| Hans Clevers | 14 |
| Christine Mummery | 14 |
| Sven H. M. A. Dumoulin | 14 |
| Bruno Luc Myriam Holthof | 14 |
- Stock Market
- Insiders
- Arno de Wilde
- Company connections
